Header Logo

MATTHEW BRAMS

TitleClinical Assistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Psychiatry & Behavioral Sciences
Address550 Westcott, #520
Houston, TX 77007
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cutler AJ, Kollins SH, Brams MN, Corliss M, Oh C, Braeckman R, Childress AC. Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study. Front Psychiatry. 2024; 15:1310483. PMID: 38566957; PMCID: PMC10986733.
      Citations:    
    2. Childress AC, Marraffino A, Cutler AJ, Oh C, Brams MN. Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study. J Child Adolesc Psychopharmacol. 2023 03; 33(2):51-58. PMID: 36809150; PMCID: PMC10031142.
      Citations: 2     Fields:    Translation:Humans
    3. Kollins SH, Braeckman R, Guenther S, Barrett AC, Mickle TC, Oh C, Marraffino A, Cutler AJ, Brams MN. A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2021 11; 31(9):597-609. PMID: 34714120.
      Citations: 2     Fields:    Translation:Humans
    4. Childress AC, Brams MN, Cutler AJ, Donnelly GAE, Bhaskar S. Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study. J Child Adolesc Psychopharmacol. 2020 12; 30(10):580-589. PMID: 33090921; PMCID: PMC7757528.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    5. Childress AC, Cutler AJ, Marraffino A, McDonnell MA, Turnbow JM, Brams M, DeSousa NJ, Incledon B, Sallee FR, Wigal SB. A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings. J Child Adolesc Psychopharmacol. 2020 02; 30(1):2-14. PMID: 31464511; PMCID: PMC7041320.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    6. Wigal T, Brams M, Frick G, Yan B, Madhoo M. A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design. Postgrad Med. 2018 Jun; 130(5):481-493. PMID: 29809075.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    7. Childress AC, Wigal SB, Brams MN, Turnbow JM, Pincus Y, Belden HW, Berry SA. Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2018 06; 28(5):306-313. PMID: 29211967; PMCID: PMC5994670.
      Citations: 7     Fields:    Translation:Humans
    8. Brams M, Childress AC, Greenbaum M, Yu M, Yan B, Jaffee M, Robertson B. SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study. J Child Adolesc Psychopharmacol. 2018 02; 28(1):19-28. PMID: 28816509; PMCID: PMC5771539.
      Citations: 4     Fields:    Translation:Humans
    9. Childress AC, Brams M, Cutler AJ, Kollins SH, Northcutt J, Padilla A, Turnbow JM. The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study. J Child Adolesc Psychopharmacol. 2015 Jun; 25(5):402-14. PMID: 25692608; PMCID: PMC4491157.
      Citations: 11     Fields:    Translation:Humans
    10. Weisler RH, Babcock T, Adeyi B, Brams M. Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate. Postgrad Med. 2014 Sep; 126(5):31-41. PMID: 25295648.
      Citations: 1     Fields:    Translation:Humans
    11. Cutler AJ, Brams M, Bukstein O, Mattingly G, McBurnett K, White C, Rubin J. Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2014 Oct; 53(10):1092-101. PMID: 25245353.
      Citations: 7     Fields:    Translation:Humans
    12. Weiden PJ, Citrome L, Alva G, Brams M, Glick ID, Jackson R, Mattingly G, Kianifard F, Meng X, Pestreich L, Hochfeld M, Winseck A. A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia. Schizophr Res. 2014 Mar; 153(1-3):160-8. PMID: 24529610.
      Citations: 7     Fields:    Translation:HumansCells
    13. Silva RR, Brams M, McCague K, Pestreich L, Muniz R. Extended-release dexmethylphenidate 30 mg/d versus 20 mg/d: duration of attention, behavior, and performance benefits in children with attention-deficit/hyperactivity disorder. Clin Neuropharmacol. 2013 Jul-Aug; 36(4):117-21. PMID: 23860345.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    14. Brams M, Turnbow J, Pestreich L, Giblin J, Childress A, McCague K, Muniz R. A randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom control. J Clin Psychopharmacol. 2012 Oct; 32(5):637-44. PMID: 22926597.
      Citations: 6     Fields:    Translation:Humans
    15. Brams M, Weisler R, Findling RL, Gasior M, Hamdani M, Ferreira-Cornwell MC, Squires L. Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design. J Clin Psychiatry. 2012 Jul; 73(7):977-83. PMID: 22780921.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    16. Wilens TE, Bukstein O, Brams M, Cutler AJ, Childress A, Rugino T, Lyne A, Grannis K, Youcha S. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jan; 51(1):74-85.e2. PMID: 22176941.
      Citations: 42     Fields:    Translation:Humans
    17. Mao AR, Brams M, Babcock T, Madhoo M. A physician's guide to helping patients with ADHD find success in the workplace. Postgrad Med. 2011 Sep; 123(5):60-70. PMID: 21904087.
      Citations: 1     Fields:    Translation:Humans
    18. Mao AR, Babcock T, Brams M. ADHD in adults: current treatment trends with consideration of abuse potential of medications. J Psychiatr Pract. 2011 Jul; 17(4):241-50. PMID: 21775825.
      Citations: 6     Fields:    Translation:Humans
    19. Kollins SH, Jain R, Brams M, Segal S, Findling RL, Wigal SB, Khayrallah M. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics. 2011 Jun; 127(6):e1406-13. PMID: 21555501; PMCID: PMC3387872.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    20. Brams M, Giblin J, Gasior M, Gao J, Wigal T. Effects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD. Postgrad Med. 2011 May; 123(3):99-108. PMID: 21566420.
      Citations: 9     Fields:    Translation:Humans
    21. Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr HL. Academic, behavioral, and cognitive effects of OROS? methylphenidate on older children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Apr; 21(2):121-31. PMID: 21488750; PMCID: PMC3080768.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    22. Wigal T, Brams M, Gasior M, Gao J, Giblin J. Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Postgrad Med. 2011 Mar; 123(2):169-76. PMID: 21474905.
      Citations: 9     Fields:    Translation:Humans
    23. Brown TE, Brams M, Gasior M, Adeyi B, Babcock T, Dirks B, Scheckner B, Wigal T. Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults. Curr Med Res Opin. 2011; 27 Suppl 2:23-33. PMID: 21973229.
      Citations: 6     Fields:    Translation:Humans
    24. Manos MJ, Brams M, Childress AC, Findling RL, Jensen PS, L?pez FA. Changes in emotions related to medication used to treat ADHD. Part I: literature review. J Atten Disord. 2011 Feb; 15(2):101-12. PMID: 20876887.
      Citations: 6     Fields:    Translation:Humans
    25. Findling RL, Brams M, Childress AC, Manos MJ, Jensen PS, L?pez FA. Changes in emotions related to medication used to treat ADHD. Part II: clinical approaches. J Atten Disord. 2011 Feb; 15(2):113-21. PMID: 20858786.
      Citations: 3     Fields:    Translation:Humans
    26. Brown TE, Brams M, Gao J, Gasior M, Childress A. Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. Postgrad Med. 2010 Sep; 122(5):7-17. PMID: 20861583.
      Citations: 14     Fields:    Translation:Humans
    27. Brams M, Moon E, Pucci M, L?pez FA. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day. Curr Med Res Opin. 2010 Aug; 26(8):1809-25. PMID: 20491612.
      Citations: 11     Fields:    Translation:Humans
    28. Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J, 316 Study Group. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct. 2010 Jun 24; 6:34. PMID: 20576091; PMCID: PMC2908054.
      Citations: 56     Fields:    Translation:HumansCTClinical Trials
    29. Brams M, Mao AR, Doyle RL. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. Postgrad Med. 2008 Sep; 120(3):69-88. PMID: 18824827.
      Citations: 5     Fields:    Translation:Humans
    30. Muniz R, Brams M, Mao A, McCague K, Pestreich L, Silva R. Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study. J Child Adolesc Psychopharmacol. 2008 Jun; 18(3):248-56. PMID: 18582179.
      Citations: 16     Fields:    Translation:Humans
    31. Silva RR, Muniz R, Pestreich L, Brams M, Mao AR, Childress A, Wang J. Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):199-208. PMID: 18176337.
      Citations: 8     Fields:    Translation:Humans
    32. Silva R, Muniz R, McCague K, Childress A, Brams M, Mao A. Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting. Psychopharmacol Bull. 2008; 41(1):19-33. PMID: 18362868.
      Citations: 13     Fields:    Translation:Humans
    33. Brams M, Muniz R, Childress A, Giblin J, Mao A, Turnbow J, Borrello M, McCague K, Lopez FA, Silva R. A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect. CNS Drugs. 2008; 22(8):693-704. PMID: 18601306.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    34. Silva RR, Muniz R, Pestreich L, Childress A, Brams M, Lopez FA, Wang J. Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006 Jun; 16(3):239-51. PMID: 16768632.
      Citations: 16     Fields:    Translation:Humans
    35. Silva R, Muniz R, Pestreich LK, Brams M, Childress A, Lopez FA. Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting. J Child Adolesc Psychopharmacol. 2005 Aug; 15(4):637-54. PMID: 16190795.
      Citations: 19     Fields:    Translation:Humans
    BRAMS's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (101)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _